Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun 26:9:205.
doi: 10.1186/1471-2407-9-205.

Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy

Hyo Song Kim  1 , Jeeyun Lee, Seong Yoon Yi, Hyun Jung Jun, Yoon-La Choi, Geung Hwan Ahn, Sung Wook Seo, Do Hoon Lim, Yong Chan Ahn, Joon Oh Park, Sung Joo Kim
Affiliations

Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy

Hyo Song Kim et al. BMC Cancer. .

Abstract

Background: Prognosis and optimal treatment strategies of liposarcoma have not been fully defined. The purpose of this study is to define the distinctive clinical features of liposarcomas by assessing prognostic factors.

Methods: Between January 1995 and May 2008, 94 liposarcoma patients who underwent surgical resection with curative intent were reviewed.

Results: Fifty patients (53.2%) presented with well differentiated, 22 (23.4%) myxoid, 15 (16.0%) dedifferentiated, 5 (5.3%) round cell, and 2 (2.1%) pleomorphic histology. With the median 14 cm sized of tumor burden, about half of the cases were located in the retroperitoneum (46.8%). Seventy two (76.6%) patients remained alive with 78.1%, and 67.5% of the 5- and 10-year overall survival (OS) rates, respectively. Low grade liposarcoma (well differentiated and myxoid) had a significantly prolonged OS and disease free survival (DFS) with adjuvant radiotherapy when compared with those without adjuvant radiotherapy (5-year OS, 100% vs 66.3%, P = 0.03; 1-year DFS, 92.9% vs 50.0%, respectively, P = 0.04). Independent prognostic factors for OS were histologic variant (P = 0.001; HR, 5.1; 95% CI, 2.0 - 12.9), and margin status (P = 0.005; HR, 4.1; 95% CI, 1.6-10.5). We identified three different risk groups: group 1 (n = 66), no adverse factors; group 2, one or two adverse factors (n = 28). The 5-year OS rate for group 1, and 2 were 91.9%, 45.5%, respectively.

Conclusion: The histologic subtype, and margin status were independently associated with OS, and adjuvant radiotherapy seems to confer survival benefit in low grade tumors. Our prognostic model for primary liposarcoma demonstrated distinct three groups of patients with good prognostic discrimination.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival of all patients.
Figure 2
Figure 2
Overall survival according to adjuvant radiotherapy for patients with low grade sarcomas (A) and high grade liposarcomas (B).
Figure 3
Figure 3
Overall survival of patients by prognostic model. Group 1 (n = 66), no adverse factors; Group 2, one or two adverse factors (n = 28).
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96. doi: 10.3322/CA.2007.0010. - DOI - PubMed
    1. ECDM Fletcher KU, Mertens F. World Health Organisation: classificationo of tumors: pathology and genetics of tumours of soft tissue and bone. IARC Press; 2002. pp. 35–46.
    1. Miettinen M. Diagnostic soft tissue pathology. Oxford, Churchill Livingstone; 2003. pp. 1450–1408.
    1. Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18(8):1637–1643. - PubMed
    1. Orson GG, Sim FH, Reiman HM, Taylor WF. Liposarcoma of the musculoskeletal system. Cancer. 1987;60(6):1362–1370. doi: 10.1002/1097-0142(19870915)60:6<1362::AID-CNCR2820600634>3.0.CO;2-1. - DOI - PubMed

LinkOut - more resources